ALAN TANNENBAUM: Open Payments
NPI 1235117342 · CAPE CORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$473 in 13 payments from 7 companies in 2025. Trend: 2023 $435 · 2024 $978 · 2025 $473
Food & beverage: $473
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Boston Scientific Corporation | 1 | $99 |
| PFIZER INC. | 3 | $65 |
| Lilly USA, LLC | 2 | $60 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Merck Sharp & Dohme LLC | 2 | $53 |
| Medtronic, Inc. | 1 | $17 |
Products named: BREZTRI, Intracept, JARDIANCE, TRELEGY ELLIPTA, GARDASIL 9, PREVNAR 20, ELIQUIS, VENASEAL.
Industry payments across FL — which companies pay providers there.
